Rufinamide Tablet, Film Coated
Product Images NDC 0054-0426

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Rufinamide (NDC 0054-0426). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem (Image 01)

FDA Label Image

Btl1 (Image 02)

This is a description of a medication called Rufinamide in tablet form, with each tablet containing 200 mg of the active ingredient. The medication should be stored at a temperature between 15°C and 30°C, and protected from moisture. The prescriber's information should be consulted for dosage information. The medication should be kept out of reach of children. The medication is distributed by Hikma Pharmaceuticals USA Inc. in Berkeley Heights, NJ. A Medication Guide is included and should be read prior to dispensing.*

FDA Label Image

Btl2 (Image 03)

This text is a description of the medication "Rufinamide Tablets, USP". Each tablet contains 400mg of Rufinamide. Storage instructions and usual dosage are given, and it is emphasized to keep the medicine out of the reach of children. The NDC number for the tablets is given, and it is advised to dispense with the medication guide. The distribution of the medication is done by Hikma Pharmaceuticals USA Inc. However, there is some unreadable text at the end.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.